Senate Democrats say they plan to challenge a congressman’s decision to slap a proposal sponsored by Sen. Raphael Warnock (D-Ga.) to cap insulin prices from the Cut Inflation Act, according to a Democrat familiar with the plan.
Currently, Warnock’s proposal to cap insulin costs at $35 a month is in the bill, but the congressman is expected to rule in the Senate that he violates the Byrd Rule, which prohibits the policy making in the budget. reconciliation invoices that have an indirect impact on expenses and revenues.
But Democrats plan to challenge the congressman’s ruling on the floor, which means they would need 60 votes to lift an objection to keeping the insulin provision in the bill.
Any effort to unseat the congressman likely won’t get 10 Republican votes, but it will put Republicans on the record as opposing a $35 monthly cap on patient insulin costs, which Democrats can use as ammunition policies in the midterm elections.
“I think it’s hard for elected officials to go home, when everyone is heading now, and try to explain, if they choose to vote that way, why they don’t support the helps the millions of Americans who are being crushed by those insulin bills. “said Senate Finance Committee Chairman Ron Wyden (D-Ore.) before the floor showdown.
Maine Sen. Susan Collins (R) said it was “unfortunate” that Democrats were turning the issue into political football.
Collins sponsored a bipartisan bill with Sen. Jeanne Shaheen (DN.H.) to reduce insulin costs.
Their bill would encourage insulin makers to lower their list prices and limit out-of-pocket payments for patients with diabetes by ensuring that group and individual health plans in the marketplace waive deductibles and cost-sharing to a maximum of $35 per month, according to a summary. provided by their offices.
“I think it’s unfortunate that he was included” in the reconciliation package, Collins said of the insulin proposal which is expected to be rejected on the court on Saturday.
Mychael Schnell contributed.